Atossa Therapeutics Announces Successful In Vitro Testing of Nasal Spray Formulation: AT-301 Inhibits SARS-CoV-2 Infectivity of VERO Cells in Laboratory Culture

Results Support Development of Proprietary AT-301 Nasal Spray for COVID-19 Patients

Get A Free Gift

Your Mammogram: The Questions to Ask Before, During, and After Your Exam